CID 16186540

5'-(3,4-dibenzyloxybenzyl-d(tgggag)-3'-phosphorothioate, hydroxyethyl ester

Structural Information

Molecular Formula
C83H97N27O39P6S
SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COCC3=CC(=C(C=C3)OCC4=CC=CC=C4)OCC5=CC=CC=C5)OP(=O)(O)OC[C@@H]6[C@H](C[C@@H](O6)N7C=NC8=C7N=C(NC8=O)N)OP(=O)(O)OC[C@@H]9[C@H](C[C@@H](O9)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OC[C@@H]1[C@H](CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCCO
InChI
InChI=1S/C83H97N27O39P6S/c1-39-23-105(83(117)104-74(39)112)57-17-45(51(138-57)27-129-24-42-12-13-43(130-25-40-8-4-2-5-9-40)44(16-42)131-26-41-10-6-3-7-11-41)144-150(118,119)133-29-53-47(19-59(140-53)107-35-92-64-70(107)96-79(85)100-75(64)113)147-152(122,123)135-31-55-49(21-61(142-55)109-37-94-66-72(109)98-81(87)102-77(66)115)148-153(124,125)136-30-54-48(20-60(141-54)108-36-93-65-71(108)97-80(86)101-76(65)114)146-151(120,121)134-28-52-46(18-58(139-52)106-34-91-63-68(84)89-33-90-69(63)106)145-154(126,127)137-32-56-50(149-155(128,156)132-15-14-111)22-62(143-56)110-38-95-67-73(110)99-82(88)103-78(67)116/h2-13,16,23,33-38,45-62,111H,14-15,17-22,24-32H2,1H3,(H,118,119)(H,120,121)(H,122,123)(H,124,125)(H,126,127)(H,128,156)(H2,84,89,90)(H,104,112,117)(H3,85,96,100,113)(H3,86,97,101,114)(H3,87,98,102,115)(H3,88,99,103,116)/t45-,46-,47-,48-,49-,50-,51+,52+,53+,54+,55+,56+,57+,58?,59+,60+,61+,62+,155?/m0/s1
InChIKey
JHFMHTBSWMRVOO-RFKKZRSGSA-N
Compound name
[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[hydroxy(2-hydroxyethoxy)phosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methyl [(2R,3S,5R)-2-[[3,4-bis(phenylmethoxy)phenyl]methoxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2313.4583 Da
Monoisotopic Mass

-7.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2314.4656 243.0
[M+Na]+ 2336.4475 254.2
[M-H]- 2312.4510 243.4
[M+NH4]+ 2331.4921 246.9
[M+K]+ 2352.4215 250.1
[M+H-H2O]+ 2296.4556 241.8
[M+HCOO]- 2358.4565 247.8
[M+CH3COO]- 2372.4722 249.4
[M+Na-2H]- 2334.4330 252.5
[M]+ 2313.4578 253.0
[M]- 2313.4588 253.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.